RBM Partnership Approves Reformed Structure

Margaret ArbogastArticle, News

The Roll Back Malaria Partnership Board approved a new Governance Framework at its 29th Board Meeting in Geneva which will refine and refocus the current Partnership to better advocate for and attract increased attention to the global malaria fight for the next fifteen years. Part of this Board approval will see the creation of a high-level Malaria Council, a Partnership … Read More

Margaret ArbogastRBM Partnership Approves Reformed Structure

Statement from the Private Sector Constituency to the Roll Back Malaria Partnership on the Passing of Alan Magill

Margaret ArbogastNews

The Private Sector Constituency of the Roll Back Malaria Partnership Board is deeply saddened by the sudden loss of our colleague and friend Alan Magill. Many of us worked closely with Alan during his time at the Gates Foundation. We all admired his visionary leadership of the Malaria Portfolio as he challenged not only his team but us too in … Read More

Margaret ArbogastStatement from the Private Sector Constituency to the Roll Back Malaria Partnership on the Passing of Alan Magill

Meet the Members Council: Jean-Marc Bouchez and Nicole Malick

Nisa PatelNews

Jean-Marc Bouchez Chief Medical Officer, General Manager, Guilin Pharmaceutical Co., Ltd. Nicole Malick Corporate Social Responsibility Manager, NRS International (TANA Netting)   Tell us a little about your company’s approach to malaria control and elimination. In the last few years, Guilin Pharma has conducted different innovative campaigns and programs in malaria prevention and control. As the innovator of injectable artesunate … Read More

Nisa PatelMeet the Members Council: Jean-Marc Bouchez and Nicole Malick

A Closer Look: Malaria R&D Challenges And How To Address Them

Nisa PatelNews

Sustaining the gains achieved in malaria control and prevention during the MDG era as we transition to the SDGs will require an ongoing commitment to research and development (R&D) of new tools, including drugs, diagnostics and health products. With up to two-thirds of malaria-endemic countries facing artemisinin resistance, and pyrethroid insecticide resistance rising throughout Africa with no available alternatives, elimination … Read More

Nisa PatelA Closer Look: Malaria R&D Challenges And How To Address Them

RBM Private Sector Members Council News – August 2015

Nisa PatelArticle

BASF BASF and University of Göttingen Scientists Find New Specific Insecticide Target Protein BAYER Bayer Publishes a view into the future insecticide landscape for malaria vector control EXXONMOBIL ExxonMobil Announces $10 Million in New Grants To Raise Public Awareness of Malaria GUILIN PHARMACEUTICALS Guilin Pharma Launches Anti-Malaria Film In Africa GLAXOSMITHKLINE Positive results from Phase II trial of Malaria vaccine … Read More

Nisa PatelRBM Private Sector Members Council News – August 2015